Use of panitumumab in the treatment of acinar cell carcinoma of the pancreas: A case report

Distler M, Rückert F, Dittert DD, et al: Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy. World J Surg Oncol. 7:222009. View Article : Google Scholar : PubMed/NCBI

Ohori NP, Khalid A, Etemad B and Finkelstein SD: Multiple loss of heterozygosity without K-ras mutation identified by molecular analysis on fine-needle aspiration cytology specimen of acinar cell carcinoma of pancreas. Diagn Cytopathol. 27:42–46. 2002. View Article : Google Scholar : PubMed/NCBI

De la O JP and Murtaugh LC: Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signalling. Cell Cycle. 8:1860–1864. 2009.PubMed/NCBI

Royal RE, Wolff RA and Crane CH: Pancreatic cancer. CANCER: Principles & Practice of Oncology. DeVita V, Lawrence TS and Rosenberg SA: Wolter Kluver/Lippincott Williams & Wilkins; Philadelphia: pp. 1086–1123. 2008

Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, et al: Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma. Frequent allelic loss on chromosome 11p and alterations in the APC/beta catenin pathway. Am J Pathol. 160:953–962. 2002. View Article : Google Scholar : PubMed/NCBI

Holen KD, Klimstra DS, Hummer A, et al: Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol. 20:4673–4678. 2002. View Article : Google Scholar : PubMed/NCBI

Schmidt CM, Matos JM, Bentrem DJ, Talamonti MS, Lillemoe KD and Bilimoria KY: Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 12:2078–2086. 2008. View Article : Google Scholar : PubMed/NCBI

Antoine M, Khitrik-Palchuk M and Saif MW: Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature. JOP. 8:783–789. 2007.PubMed/NCBI

Dewald GW, Smyrk TC, Thorland EC, et al: Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma and islet cell carcinoma of the pancreas. Mayo Clin Proc. 84:801–810. 2009. View Article : Google Scholar

Van Custem E, Peeters M, Siena S, et al: Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol. 25:1658–1664. 2007.PubMed/NCBI